Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Drug Chem Toxicol ; 40(2): 191-195, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27387265

ABSTRACT

The genotoxicity and mutagenicity of Halfenprox, a synthetic pyrethroid insecticide and acaricide, was assessed using two standard genotoxicity assays of the Salmonella typhimurium mutagenicity assay (Ames test) and in vitro micronucleus (MN) assay in human peripheral lymphocytes. In the Ames test, Salmonella strains TA98 and TA100 were treated with or without S9 fraction. The doses of Halfenprox were 6.25, 12.5, 25, 50, and 100 µg/plate and test materials were dissolved in DMSO. The concentrations of Halfenprox did not show mutagenic activity on both strains with and without S9 fraction. The MN assay was used to investigate the genotoxic effects of Halfenprox in human peripheral lymphocytes treated with 250, 500, 750, and 1000 µg/ml concentrations of Halfenprox for 24 and 48 h, and at 1000 µg/ml the concentration was significantly increased and the MN formation was compared with the negative control for both treatment periods. In addition, a significant decrease of the nuclear devision index (NDI) values at the higher concentrations of Halfenprox and at both treatment periods was observed.


Subject(s)
Acaricides/toxicity , DNA, Bacterial/drug effects , Insecticides/toxicity , Micronuclei, Chromosome-Defective/chemically induced , Micronucleus Tests , Mutation , Phenyl Ethers/toxicity , Pyrethrins/toxicity , Salmonella typhimurium/drug effects , DNA, Bacterial/genetics , Dose-Response Relationship, Drug , Humans , Risk Assessment , Salmonella typhimurium/genetics , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...